Pathway Financial Advisers LLC Purchases 7,665 Shares of Cabot Co. (NYSE:CBT)

Pathway Financial Advisers LLC raised its position in shares of Cabot Co. (NYSE:CBT - Free Report) by 11,108.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,734 shares of the specialty chemicals company's stock after buying an additional 7,665 shares during the period. Pathway Financial Advisers LLC's holdings in Cabot were worth $864,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. Wolff Wiese Magana LLC acquired a new position in Cabot during the 3rd quarter worth about $25,000. CWM LLC grew its stake in shares of Cabot by 60.6% during the second quarter. CWM LLC now owns 416 shares of the specialty chemicals company's stock valued at $38,000 after purchasing an additional 157 shares during the last quarter. UMB Bank n.a. increased its holdings in shares of Cabot by 53.9% in the third quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company's stock valued at $41,000 after purchasing an additional 130 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in Cabot by 33.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company's stock worth $48,000 after purchasing an additional 119 shares during the last quarter. Finally, 1620 Investment Advisors Inc. acquired a new position in Cabot during the 2nd quarter worth $49,000. Institutional investors own 93.18% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. boosted their target price on Cabot from $95.00 to $105.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 7th. UBS Group dropped their price objective on Cabot from $103.00 to $98.00 and set a "neutral" rating for the company in a report on Tuesday, August 6th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $101.75.

Cabot Trading Down 1.0 %

NYSE CBT traded down $1.13 on Friday, reaching $109.26. The company had a trading volume of 264,720 shares, compared to its average volume of 331,858. Cabot Co. has a 52 week low of $65.10 and a 52 week high of $117.14. The stock's 50 day moving average is $107.40 and its 200-day moving average is $100.31. The company has a quick ratio of 1.45, a current ratio of 2.22 and a debt-to-equity ratio of 0.72. The stock has a market cap of $6.04 billion, a price-to-earnings ratio of 13.83, a PEG ratio of 0.93 and a beta of 1.19.

Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings results on Monday, August 5th. The specialty chemicals company reported $1.92 EPS for the quarter, beating analysts' consensus estimates of $1.72 by $0.20. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1 billion. Cabot had a return on equity of 26.99% and a net margin of 12.05%. Cabot's revenue was up 5.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.42 EPS. Equities analysts predict that Cabot Co. will post 7.07 earnings per share for the current year.

Insider Activity

In other Cabot news, CFO Erica Mclaughlin sold 23,274 shares of Cabot stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the transaction, the chief financial officer now directly owns 59,814 shares in the company, valued at approximately $5,968,839.06. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CFO Erica Mclaughlin sold 23,274 shares of the stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the completion of the sale, the chief financial officer now directly owns 59,814 shares of the company's stock, valued at approximately $5,968,839.06. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Hobart Kalkstein sold 5,457 shares of Cabot stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total transaction of $548,865.06. Following the completion of the transaction, the executive vice president now directly owns 61,688 shares in the company, valued at approximately $6,204,579.04. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 71,939 shares of company stock valued at $7,308,812 in the last quarter. Company insiders own 3.07% of the company's stock.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.